Effect of Moringa oleifera Lam. Seed extract on ovalbumin-induced airway inflammation in guinea pigs

Inhalation Toxicology

Volumn 20, Issue 10, 2008, Pages 897-909

  Mahajan, Shailaja G ^a   Mehta, Anita A ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HISTAMINE; INTERLEUKIN 4; INTERLEUKIN 6; MORINGA OLEIFERA EXTRACT; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

AEROSOL; AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BREATHING RATE; BRONCHOSPASM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; GUINEA PIG; HISTOPATHOLOGY; HOMOGENATE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MALE; MORINGA OLEIFERA; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TIDAL VOLUME; TRACHEA;

ACETYLCHOLINE; ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; LUNG; MALE; MORINGA OLEIFERA; OVALBUMIN; PLANT EXTRACTS; PNEUMONIA; SEEDS;

ANIMALIA; CAVIA; MORINGA OLEIFERA; MORINGACEAE;

EID: 49349100637     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370802027443     Document Type: Article

References (88)

1. H2 like cells in allergy and asthma: Pharmacological perspectives. Trends Pharmacol. Sci. 15:324-332.
2. Barnes, P. J. 1996. Pathophysiology of asthma. Br. J. Clin. Pharmacol. 42:3-10.
3. Barnes, P. J., Chung, K. F., and Page, C. P. 1998. Inflammatory mediators of asthma. Pharmacol. Rev. 50:515-596.
4. Bartosch, H., Feldberg, W., and Nagel, E. 1932. Das Freiwerden eines histaminahnlichen stoffes bei der anaphylaxie der Meerschwein chens. Pflungers. Arch. Ges. Physiol. 230:120-153.
5. H 1-skewed cytokine production in ovalbumin-sensitized mice. J. Ethnopharmacol. 95:191-197.
6. Bousquet, J., Chanez, P., and Lacoste, J. Y. 1990. Eosinophilic inflammation in asthma. N Engl. J. Med. 323:1033-1039.
7. Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M., and Vignola, A. M. 2000. Asthma: From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161:1720-1745.
8. Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C. H., Howarth, P. H. and Holgate, S. T. 1994. Interleukins-4, -5 and -6, and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471-480.
9. Broide, D. H., and Firestein, G. S. 1991. Endobronchial allergen challenge: Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J. Clin. Invest. 88:1048-1053.
10. Broide, D. H., Lotz, M., Cuomo, A. J, Coburn, D. A, Federman, E. C., and Wasserman, S. I. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
11. Caceres, A., Cebreva, O., Morales, O., Miollined, P., and Mendia, P. 1991. Pharmacological properties of M. oleifera 1. Preliminary screening for antimicrobial activity. J. Ethnopharmacol. 33:213-216.
12. Caceres, A., Saravia, A., Rizzo, S., Zabala, L., De-Leon, E., and Nave, F. 1992. Pharmacological properties of M. oleifera 2. Screening for antispasmodic, anti-inflammatory and diuretic activity. J. Ethnopharmacol. 36:233-237.
13. Chaudhri, R. D. 1996. Herbal drug industry: A practical approach to industrial pharmacognosy, ed. R. D. Chaudhri, pp. 58-62. New Delhi: Eastern Publisher.
14. Chitravanshi, V. C., Gupta, P. P., Kulshrestha, D. K., Kar, K., and Dhawan, B. N. 1990. Anti-allergic activity of Solanum xanthocarpum. Ind. J. Pharmacol. 22:23-24.
15. Chopra, R. N., Chopra, I. C., Handa, K., and Kapur, D. 1938. Chopra's indigenous drugs of India. Calcutta: Dhur.
16. Christofidou-Solomidou M., and Muzykantov, V. R. 2006. Antioxidant strategies in respiratory medicine. Treat. Respir. Med. 5:47-78.
17. Chung, K. F., and Adcock, I. 2000. Application of cell and molecular biology techniques to unravel causes and pathophysiological mechanisms. In Asthma mechanisms and protocols, eds. K. F. Chungand I. Adcock, pp. 1-29. Totowa, NJ: Humana Press.
18. Chung, K. F., and Barnes, P. J. 1999. Cytokines in asthma. Thorax 54:825-857.
19. Cohen, H. A., Rundell, K. W., Evans, T. M., and Levine, A. M. 1997. Blocking effects of vitamin C exercise-induced asthma. Arch. Pediatr. Adolesc. Med. 151:367-370.
20. Cohen, L., and Ray, A. 2000. T-helper type-2 cell-mediated therapy for asthma. Pharmacol. Ther. 88:187-196.
21. Coker, R. K., and Laurent, G. J. 1998. Pulmonary fibrosis: Cytokines in the balance. Eur. Respir. J. 11:1218-1221.
22. Dahot, M. U., and Memon, A. R. 1985. Nutritive significance of oil extracted from Moringa oleifera seeds. J. Pharm. Univ. Karachi 3:75-80.
23. Das, B. R., Kurup, P. A., and Narasimha Rao, P. L. 1958. Antibiotic principle from Moringa pterosperma Part IX. Inhibition of transaminase by isocyanates. Ind. J. Med. Res. 46:75-77.
24. Dayrit, F. M., Alcantara, A. D., and Villasenor, I. M. 1990. The antibiotic compound and its deactivation in aqueous solution. Phil. J. Sci. 119:23-26.
25. Devillier, P., and Bessard, G. 1997. Thromboxane A2 and related prostaglandins in airways. Fundam. Clin. Pharmacol. 11:2-18.
26. Duan, W., Kua, I. C., Selvarajan, S., Chua, K. Y., Bay, B. H., and Wong, W. S. 2003. Anti-inflammatory effects of genistein, a tyrosine kinase inhibitor, on guinea pig model of asthma. Am. J. Respir. Crit. Care Med. 167:185-192.
27. Elias, J. A., Wu, Y., Zheng, T., and Panettieri, R. 1997. Cytokine and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am. J. Physiol. 273:L648-L655.
28. Faizi, S., Siddiqui, B. S., Saleem, R., Siddiqui, S., Aftab, K., and Gilani, A. H. 1995. Fully acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry (Oxford) 38:957-963.
29. Filipovic, M., and Snezana, C. 2001. The role of eosinophils in asthma. Med. Biol. 8:6-10.
30. Frigas E., Loegering, D. A., and Gleich, G. J. 1980. Cytotoxic properties of the eosinophil major basic protein on tracheal epithelium. Lab Invest. 42:35-43.
31. Gharaee-Kermani, M., Nozaki, Y., Hatano, K., and Phan, S. H. 2001. Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokines 15:138-147.
32. Gokhale, A. B., Dikshit, V. J., Damre, A. S., Kulkarni, K. R., and Saraf, M. N. 2000. Influence of ethanolic extract of Tephrosia purpurea Linn. on mast cells and erythrocytes membrane integrity. Ind. J. Exp. Biol. 38:837-840.
33. Gosset, P., Tsicopoulos, A., Wallaert, B., Vannimenus, C., Joseph, M., Tonnel, A. B. and Capron, A. 1991. Increased secretion by tumor necrosis factor-α and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J. Allergy Clin. Immunol. 88:561-571.
34. Guevara, A. P., Vargas, C., Sakurai, H., Fujiwara, Y., Hashimoto, K., Maoka, T., Kozuka, M., Ito, Y., Tokuda, H., and Nishino, H. 1999. An antitumor promoter from Moringa oleifera Lam. Mutat. Res. 440:181-188.
35. Gundel, R. H., Wagner, C. D., and Letts, G. 1992. The onset and recovery from hyperresponsiveness: relationship with inflmmatory cell infiltrates and release of cytotoxic granule proteins. Clin. Exp. Allergy 22:303-308.
36. Hirata, N., Kohrogi, H., Iwagoe, H., Goto, E., Hamamoto, J., Fujii, K., Yamaguchi, T., Kawano, O., and Ando, M. 1998. Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus: Time course and the role of cytokines. Am. J. Respir. Cell Mol. Biol. 18:12-20.
37. Holgate, S. T., and Finnerty, J. P. 1989. Anti-histamines in asthma. J. Allergy Clin. Immunol. 83:537-547.
38. Hughes, J. M., Stringer, R. S., Black, J. L., and Armour, C. L. 1995. The effects of tumor necrosis factor-α on mediator release from human lung. Pulmon. Pharmacol. 8:31-36.
39. Hui, K. P., Taylor, I. K., Taylor, and G. W. 1991. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 46:184-189.
40. Ind, P. W., Barnes, P. J., Brown, M. J., Causen, R., and Dollery, C. T. 1983. Measurement of plasma histamine. Clin. Allergy 13:61-67.
41. Ishimitsu, R., Nishimura, H., Kawauchi, H., Kawakita, K., and Yoshikai, Y., 2001. Dichotomous effect of a traditional Japanese medicine, Bu-zhong-yi-qi-tang on allergic asthma in mice. Int. Immunopharmacol. 1:857-865.
42. Karadi, R. V., Gadge, N. B., Alagawadi, K. R., Savadi, R. V., Mannur, V. S., and Kotti, B. C. 2006. Anti-arthritic activity of extracts of Moringa oleifera Lam. roots. Indian Drugs 43:543-547.
43. Kips, J. C., Tavernier, J., and Pauwels, R. A. 1992. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145:332-336.
44. Kirtikar, K. R., and Basu, B. D. 1975. Indian Medicinal Plants, 2nd ed., Vol. 1, eds. D. Dun, B. Singh, and M. P. Singh, pp. 676-683. Dehradun: M/s Bishen Singh Mahendra Pal Singh.
45. Laandrault, N., Pouchert, P., Ravel, P., Gase, F., Cros, G., and Teissedro, P. L. 2001. Antioxidant activities phenolic level of French wines from different varieties and vintages. J. Agric. Food Chem. 49:3341-3343.
46. Lin, J. Y., Chen, M. L., Chiang, B. L., and Lin, B. F. 2006. Ganoderma tsugae supplementation alleviates bronchoalveolar inflammation in an airway sensitization and challenge mouse model. Int. Immunopharmacol. 6:241-251.
47. Liu, M. C., Hubbard, W. C., Proud, D., Stealey, B. A., Galli, S. J., Kagey-Sobotka, A., Bleecker, E., and Lichtenstein, L. M. 1991. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: Cellular, mediator and permeability changes. Am. Rev. Respir. Dis. 144:51-58.
48. Mahajan S. G., Mali, R. G., and Mehta, A. A. 2006. Antianaphylactic and antiinflammatory activity of hydroalcoholic extract of leaves of Moringa oleifera. Planta Indica 2:9-13.
49. Mahajan, S. G., and Mehta, A. A. 2007. Inhibitory action of ethanolic extract of seeds of Moringa oleifera Lam. on systemic and local anaphylaxis. J. Immunotoxicol. 4(4):287-294.
50. Mahajan, S. G., Mali, R. G., and Mehta, A. A. 2007a. Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats. J. Immunotoxicol. 4:39-47.
51. Mahajan, S. G., Mali, R. G., and Mehta, A. A. 2007b. Effect of Moringa oleifera Lam. seed extract on toluene diisocyanate-induced immune-medicated inflammatory responses in rats. J. Immunotoxicol 4:85-96.
52. Masahiro, I., Shoji, N., and Yutaka, E. 2002. Effect of isolation on classical conditioned histamine release in guinea pigs. Neurosci. Res. 44:31-35.
53. Memon, G. M., and Khatri, L. M. 1987. Isolation and spectroscopic studies of mono-palmitic, di-oleic triglyceride from seeds of Moringa oleifera Lam. Pak. J. Sci. Ind. Res. 30:393-395.
54. Memon, G. M., Memon, S. A., and Memon, A. R. 1985. Isolation and structure elucidation of moringyne, a new glycoside from the seeds of M. oleifera. Pak. J. Sci. Ind. Res. 28:7-9.
55. Michael, L., and Horst, K. 1998. Synthesis of active principles from the leaves of Moringa oleifera using S-pent-4-enyl thioglycosides. Carbohydr. Res. 312:33-44.
56. Motojima, S., Frigas, E., Loegering, D. A., and Gleich, G. J. 1989. Toxicity of eosinophil cationic proteins for guinea-pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 139:801-805.
57. Mughal, M. H., Ali, G., Srivastava, P. S., and Iqbal, M. 1999. Improvement of drumstick (Moringa pterygosperms Gaertn.) a unique source of food and medicine through tissue culture. Hamdard Med. 42:37-42.
58. Nadkarni, K. M., and Nadkarni, A. K., eds. 1976. Indian materia medica, Vol. 1, pp. 811-816. Mumbai: Popular Prakashan.
59. Nair, A. M., and Saraf, M. N. 1995. Inhibition of antigen and compound 48/80 induced contractions of guinea pig trachea by the ethanolic extract of the leaves of Vitex negundo Linn. Ind. J. Pharmacol. 27:230-233.
60. Nayampalli, S., Desai, N. K., and Ainapure, S. S. 1986. Anti-allergic properties of Tinospora cordifolia in animal models. Ind. J. Pharmacol. 18:250-252.
61. Njoku, O. U., and Adikwu, M. U. 1997. Investigation on some physicochemical antioxidant and toxicological properties of Moringa oleifera seed oil. Acta Pharm. Zagr. 47:287-290.
62. Ogunbiyi, P. O., and Eyre P. 1985. Pharmacological studies of pulmonary anaphylaxis in vitro. Agents Action 17:158-173.
63. Ohkawara, Y., Yamauchi, K., Tanno, Y., Tamura, H., Outani, H., Nagura, H., Ohkuda, K., and Takishima, T. 1992. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am. J. Respir. Cell Mol. Biol. 7:385-392.
64. Ohno, I., Ohkawara, Y., Yamauchi, K., Tanno, Y., and Takishima, T. 1990. Production of tumour necrosis factor with IgE receptor triggering from sensitized lung tissue. Am. J. Respir. Cell Mol. Biol. 3:285-289.
65. Ordonez, C. L., Shaughnessy, T. E., Matthay, M. A., and Fahy, J. V. 2000. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am. J. Respir Crit. Care. Med. 161:1185-1190.
66. Paech, D., and Tracey, M. V., eds. 1955. Modern methods of plant analysis, Vol. IV, pp. 373-374. Berlin: Springer-Verlag.
67. Pretolani, M., Ruffie, C., Joseph, D., Campos M. G., Church M. K., Lefort, J., and Vargaftig, B. 1994. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am. J. Respir. Crit. Care Med. 149:1167-1174.
68. Raible, D. G., Lenahan, T., Fayvilevich, Y., Kosinski, R., and Schulman, E. S. 1994. Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am. J. Respir. Crit. Care Med. 149:1506-1511.
69. Rajan, B. K. 1986. Apiculture and farm forestry in semi-acid tracts of Karnataka. My For. 22:41-49.
70. Ricci, M., Matucci, A., and Rossi, O. 1994. Recent advances in the pathogenetic mechanisms and genetic aspects of atopic diseases. Allergy. Clin. Immunol. News. 6:103-108.
71. H2-1ike bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
72. Saria, A., Lundberg, M. J., Skoftsch, G., and Lembeck, F. 1983. Vascular protein leakage in various tissues is induced by substance P, capsaicin, bradykinin, serotonin, histamine, and by antigen challenge. Arch. Pharmacol. 324:212-218.
73. Sergio, R. 2000. The role of lymphocytes in allergic diseases. J. Allergy Clin. Immunol. 105:399-408.
74. Shore, P. A., Burkhalter, A., and Cohn, V. H. 1959. A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127:182-186.
75. Singh, R. K, Bhattacharya, S. K., and Acharya, S. B. 2000. Studies on extracts of Elaeocarpus sphaericus fruits on in vitro rat mast cells. Phytomedicine 7:205-207.
76. Sur, S., Crotty, T. B., and Kephart, G. M. 1993. Sudden onset fatal asthma: A distinct clinical entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148:713-719.
77. Theoharidesa, T. C., and Cochraned, D. E. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146:1-12.
78. Tripathi, R. M., and Das, P. K. 1977. Studies on anti-asthmatic and anti-anaphylactic activity of Albizzia lebbeck. Ind. J. Pharmacol. 9:189-194.
79. Varier, V. P. 1997. Indian medicinal plants compendium of 500 species, Vol. 4, eds. P. K. Warrier, V. P. Nambiar, and C. Ramankutty, pp. 58-62. Madras: Orient Longman.
80. Villasenor, I. M. 1994. Bioactive metabolites from Moringa oleifera Lam. Kimika 110:47-52.
81. Villasenor, I. M., Dayrit, F., and Lim-Sylianco, C. Y. 1990. Studies on M. oleifera seeds, Part II. Thermal degradation of roasted seeds. Phil. J. Sci. 119:33-39.
82. Villasenor, I. M., Lim-Sylianco, C. Y., and Dayrit, F. 1989. Mutagens from roasted seeds of Moringa oleifera. Mutat. Res. 224:209-212.
83. Wardlaw, A. J., Dunnette, S., Gleich G. J., Collins, J. V., and Kay, A. B. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
84. Wenzel, S. E., Szefler, S. J., and Leung, D. Y. 1997. Bronchoscopic evaluation of severe asthma. Am. J. Respir Crit. Care Med. 156:737-743.
85. Ying, S., Humbert, M., Barkans, J., Corrigan, C. J., Pfister, R., Menz, G., Larche, M., Robinson, D. S., Durham, S. R., and Kay, A. B. 1997. Expression of IL-4 and IL-5 mRNA and protein product by CD41 and CD81 T-cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:3539-3544.
86. Ziment, I. 1997a. Alternative therapies for asthma. Curr. Opin. Pulmon. Med. 3:61-71.
87. Ziment, I. 1997b. Alternative therapies. In Asthma, eds. P. J. Barnes, M. M. Grunstein, A. R. Leff, and A. J. Woolcock, pp. 1689-1705. Philadelphia: Lippincott-Raven.
88. Ziment, I., and Tashkin, D. P. 2000. Alternative medicine for allergy and asthma. J. Allergy Clin. Immunol. 106:603-614.